Vectus Biosystems LimitedASX: VBS

FDA Pre-IND Meeting Request Granted for VB0004

· Issued by Vectus Biosystems Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The FDA's detailed responses are expected by mid-November. The company aims to finalize its meeting package with the FDA to inform future clinical development stages.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/fda-pre-ind-meeting-request-granted-for-vb0004

Vectus Biosystems Limited on 6ix

Earlier from Vectus Biosystems

All Vectus Biosystems news releases